DEA Releases Drugs of Abuse Guide; Free Insulin Program Announced

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

Fri, Apr 17, 3:11 AM (1 day ago)

to me

If you are having trouble viewing this email, click here.

MUST READS DEA: 2020 Drugs of Abuse Resource Guide Now Available Jelmyto Approved for Low-Grade Upper Tract Urothelial Cancer Novo Nordisk Rolls Out Insulin Program for Patients Hit Financially Due to COVID-19 Next-Gen Rechargeable Neurostimulator Implant Approved for Urinary, Bowel Dysfunction Novel Pyruvate Kinase Activator Gets Orphan Drug Status for Sickle Cell Disease GUIDELINES IDSA Issues Guidelines for the Treatment and Management of Patients With COVID-19 COVID-19 Resource Center Featured Content 5 FACTS ABOUT REAL-WORLD DATA Conducting real-world data analyses to generate real-world evidence is becoming increasingly common. What are the applications and limitations of this practice? Find Out Now. CME/CE Spotlight PD-1 Inhibitors in Cutaneous Squamous Cell Carcinoma Tx AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME Subscribed as: bombaymann@gmail.com | Privacy Policy | Terms & Conditions Click here to update/complete your profile, or adjust your account settings. To unsubscribe from the MPR Daily Dose newsletter, click here © 2020 Haymarket Media, Inc. | 275 7th Ave, 10th Floor, New York, NY 10001